Ashley M. Lewis, M.D., F.A.C.C.

Return To Care Team



OFFICES


BIO

Dr. Lewis was born in North Carolina but spent most of her childhood and teenage years in Portland, OR. She has lived in multiple different cities for her medical training including Durham, NC, Cleveland, OH and Atlanta, GA, but she is thrilled to be back in the Research Triangle.

Her family life is very important to her. She is married to a wonderful, supportive husband and they have two children.

Dr. Lewis has played soccer for most of her life, which included playing Division I soccer at Pepperdine University. This experience helped her learn to be a leader and team player, which she feels are valuable skills for life.

In her spare time she enjoys relaxing with friends and family, going to church, running, hiking, boating, skiing and playing soccer.

FELLOWSHIP & POSTGRADUATE TRAINING

  • Fellowship, Interventional Cardiology, Emory University Hospital, Atlanta, GA
  • Fellowship, Cardiovascular Disease, Cleveland Clinic, Cleveland, OH

INTERNSHIP/RESIDENCY

  • Residency: Internal Medicine, Duke University, Durham, NC

EDUCATION

  • Medical Degree: Oregon Health & Science University, Portland, OR
  • Undergraduate Degree: Pepperdine University, Malibu, CA

CERTIFICATIONS

  • Cardiovascular Disease
  • Vascular Ultrasound (RPVI)
  • Internal Medicine

PROFESSIONAL MEMBERSHIPS

  • American Society of Internal Medicine
  • Alpha Omega Alpha Honor Medical Society

SPECIALTIES

  • General cardiology including coronary artery disease, congestive heart failure, valvular heart disease and peripheral artery disease

RESEARCH

  • Conducted a retrospective review on the effects of preformed HLA antibodies detected prior to heart transplantation on survival and acute rejection post-transplant; worked under Dr. Joseph G. Rogers, M.D., Duke Clinical Research Institute (2006-2008)

  • PUBLICATIONS/PRESENTATIONS/RESEARCH

PUBLICATIONS

  • Lewis AM, Kwon DH, Zoran B, et al. Aortic stiffness, in addition to myocardial scarring and mitral regurgitation, incrementally predicts outcomes in severe ischemic cardiomyopathy patients.  Presented at both the American College of Cardiology Scientific Sessions of 2010 and the European Society of Cardiology Meeting in 2010.

 



go to top